NCT00152893View on ClinicalTrials.gov

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
HIV Infections
Interventions
DRUG

chromium nicotinate

DRUG

Placebo

Trial Locations (1)

M5G 2C4

University Health Network - Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Foundation for AIDS Research (CANFAR)

OTHER

lead

Johane Allard

OTHER

NCT00152893 - To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities | Biotech Hunter | Biotech Hunter